COPD clinical trials in Arizona
16 studies for COPD are looking for participants at sites in Arizona.
Cities in Arizona
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Chandler Clinical Research Trials- Site Number : 8400025, Chandler
- Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114, Phoenix
- Epic Medical Research - Surprise- Site Number : 8400096, Surprise
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 22, 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Banner University Medical Center, Phoenix
Recruiting
Ages 40 to 80 · All sexes · Updated Sep 17, 2026 · NCT06035120Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Tucson Clinical Research Institute- Site Number : 8400006, Tucson
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 15, 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Phoenix
- Research Site, Phoenix
- Research Site, Phoenix
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Arizona- Tuscon, Tucson
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Phoenix
- Research Site, Scottsdale
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Phoenix
- Research Site, Phoenix
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Chandler Clinical Trials, Chandler
- Pulmonary Associates, PA, Phoenix
RecruitingPhase 2/3
Ages 35 to 80 · All sexes · Updated Aug 31, 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Gilbert
- Research Site, Mesa
- Research Site, Mesa
- and 2 more
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Aug 26, 2026 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 102, Phoenix
- GC2501 Study Site 107, Scottsdale
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Aug 11, 2026 · NCT07555483To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- DM Clinical Research - Phoenix, Phoenix
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 7, 2026 · NCT07684820STRIVE Post-Market Registry Study
- Dignity Health St. Joseph's Hospital and Medical Center, Phoenix
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT04302272SPIROMICS Study of Early COPD Progression (SOURCE)
- Mayo Clinic Arizona, Scottsdale
RecruitingObservational studyHealthy volunteers welcome
Ages 30 to 55 · All sexes · Updated Jun 3, 2026 · NCT05033990Pulmonary Rehabilitation for Rural Patients With COPD
- Mayo Clinic in Arizona, Scottsdale
Recruiting
Ages 40 and older · All sexes · Updated May 7, 2026 · NCT06847061Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Banner Health, Gilbert
Recruiting
Ages 40 to 84 · All sexes · Updated Apr 24, 2026 · NCT06891755myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Honor Health, Scottsdale
Recruiting
Ages 30 and older · All sexes · Updated Feb 6, 2025 · NCT05204888From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.